» Articles » PMID: 24294837

Mindfulness-based Cognitive Therapy for Preventing Relapse in Recurrent Depression: a Randomized Dismantling Trial

Abstract

Objective: We compared mindfulness-based cognitive therapy (MBCT) with both cognitive psychological education (CPE) and treatment as usual (TAU) in preventing relapse to major depressive disorder (MDD) in people currently in remission following at least 3 previous episodes.

Method: A randomized controlled trial in which 274 participants were allocated in the ratio 2:2:1 to MBCT plus TAU, CPE plus TAU, and TAU alone, and data were analyzed for the 255 (93%; MBCT = 99, CPE = 103, TAU = 53) retained to follow-up. MBCT was delivered in accordance with its published manual, modified to address suicidal cognitions; CPE was modeled on MBCT, but without training in meditation. Both treatments were delivered through 8 weekly classes.

Results: Allocated treatment had no significant effect on risk of relapse to MDD over 12 months follow-up, hazard ratio for MBCT vs. CPE = 0.88, 95% CI [0.58, 1.35]; for MBCT vs. TAU = 0.69, 95% CI [0.42, 1.12]. However, severity of childhood trauma affected relapse, hazard ratio for increase of 1 standard deviation = 1.26 (95% CI [1.05, 1.50]), and significantly interacted with allocated treatment. Among participants above median severity, the hazard ratio was 0.61, 95% CI [0.34, 1.09], for MBCT vs. CPE, and 0.43, 95% CI [0.22, 0.87], for MBCT vs. TAU. For those below median severity, there were no such differences between treatment groups.

Conclusion: MBCT provided significant protection against relapse for participants with increased vulnerability due to history of childhood trauma, but showed no significant advantage in comparison to an active control treatment and usual care over the whole group of patients with recurrent depression.

Citing Articles

Childhood trauma and subclinical PTSD symptoms predict adverse effects and worse outcomes across two mindfulness-based programs for active depression.

Canby N, Cosby E, Palitsky R, Kaplan D, Lee J, Mahdavi G PLoS One. 2025; 20(1):e0318499.

PMID: 39883728 PMC: 11781677. DOI: 10.1371/journal.pone.0318499.


Examining what works for whom and how in mindfulness-based cognitive therapy (MBCT) for recurrent depression: moderated-mediation analysis in the PREVENT trial.

Montero-Marin J, Hinze V, Maloney S, van der Velden A, Hayes R, Watkins E Br J Psychiatry. 2024; 1-9.

PMID: 39512158 PMC: 7617292. DOI: 10.1192/bjp.2024.178.


Perceived parental rearing styles and depression in Chinese adolescents: the mediating role of self-compassion.

Ren Y, Zhang S, Huang C, Zhang J, Jiang T, Fang Y Front Psychiatry. 2024; 15:1417355.

PMID: 39364381 PMC: 11446764. DOI: 10.3389/fpsyt.2024.1417355.


Childhood trauma and differential response to long-term psychoanalytic versus cognitive-behavioural therapy for chronic depression in adults.

Krakau L, Ernst M, Hautzinger M, Beutel M, Leuzinger-Bohleber M Br J Psychiatry. 2024; 225(4):446-453.

PMID: 39119997 PMC: 11557288. DOI: 10.1192/bjp.2024.112.


10-Week Trajectories of Candidate Psychological Processes Differentially Predict Mental Health Gains from Online Dyadic versus Mindfulness Interventions: A Randomized Clinical Trial.

Godara M, Singer T J Clin Med. 2024; 13(11).

PMID: 38893006 PMC: 11172466. DOI: 10.3390/jcm13113295.


References
1.
Crane C, Williams J . Factors Associated with Attrition from Mindfulness-Based Cognitive Therapy in Patients with a History of Suicidal Depression. Mindfulness (N Y). 2010; 1(1):10-20. PMC: 2987524. DOI: 10.1007/s12671-010-0003-8. View

2.
Williams J, Barnhofer T, Crane C, Beck A . Problem solving deteriorates following mood challenge in formerly depressed patients with a history of suicidal ideation. J Abnorm Psychol. 2005; 114(3):421-31. DOI: 10.1037/0021-843X.114.3.421. View

3.
Piet J, Hougaard E . The effect of mindfulness-based cognitive therapy for prevention of relapse in recurrent major depressive disorder: a systematic review and meta-analysis. Clin Psychol Rev. 2011; 31(6):1032-40. DOI: 10.1016/j.cpr.2011.05.002. View

4.
Nierenberg A, Husain M, Trivedi M, Fava M, Warden D, Wisniewski S . Residual symptoms after remission of major depressive disorder with citalopram and risk of relapse: a STAR*D report. Psychol Med. 2009; 40(1):41-50. PMC: 5886713. DOI: 10.1017/S0033291709006011. View

5.
Williams J, Russell I, Russell D . Mindfulness-based cognitive therapy: further issues in current evidence and future research. J Consult Clin Psychol. 2008; 76(3):524-9. PMC: 2834575. DOI: 10.1037/0022-006X.76.3.524. View